Results 61 to 70 of about 1,005,751 (338)

Radiotherapy and Phototherapy [PDF]

The American Journal of the Medical Sciences, 1902
n ...
openaire   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

Radiation Oncology, 2018
Background Despite screening campaigns, cervical cancers remain among the most prevalent malignancies and carry significant mortality, especially in developing countries. Most studies report outcomes of patients receiving the usual standard of care.
Sophie Espenel, Max-Adrien Garcia, Jane-Chloé Trone, Elodie Guillaume, Annabelle Harris, Amel Rehailia-Blanchard, Ming Yuan He, Sarra Ouni, Alexis Vallard, Chloé Rancoule, Majed Ben Mrad, Céline Chauleur, Guy De Laroche, Jean-Baptiste Guy, Pablo Moreno-Acosta, Nicolas Magné   +15 more
doaj   +1 more source

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review

Radiation Oncology, 2020
Purpose To compare the efficacy and toxicity of hypofractionated radiotherapy versus conventional fractionated radiotherapy in postmastectomy breast cancer using meta-analysis.
Lei Liu, Yongqiang Yang, Qi Guo, Bixin Ren, Qiliang Peng, Li Zou, Yaqun Zhu, Ye Tian   +7 more
doaj   +1 more source

Immune targets in the tumor microenvironment treated by radiotherapy. [PDF]

, 2019
Radiotherapy (RT), the major anti-cancer modality for more than half of cancer patients after diagnosis, has the advantage of local tumor control with relatively less systematic side effects comparing to chemotherapy.
Li, Jian Jian, Ozpiskin, Omer M, Zhang, Lu   +2 more
core  

Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer [PDF]

, 2017
Background: Prone whole breast irradiation (WBI) leads to reduced heart and lung doses in breast cancer patients receiving adjuvant radiotherapy. In this feasibility trial, we investigated the prone position for whole breast + lymph node irradiation (WB +
A Berrington de Gonzalez, AM Kirby, Annick Van Greveling, Bert Boute, Bruno Speleers, BT Gielda, BV Offersen, BV Offersen, Chris Monten, CR Jephcott, FR Bartlett, FR Bartlett, G Alco, Giselle Post, Herman Depypere, I Finke, IR Vogelius, IY Jo, J Buijsen, J Reznik, JD Boice Jr, Joris Van de Velde, K Kainz, K Verhoeven, K Verhoeven, L Veldeman, LB Marks, LB Thorsen, Leen Paelinck, Liv Veldeman, LM Sun, M Alonso-Basanta, M Feng, M Stovall, N Dogan, N Mason, P McGale, PD Inskip, Pieter Deseyne, PM Poortmans, RA Sethi, SC Darby, SC Formenti, SC Lymberis, SM Shin, T Grantzau, T Grantzau, T Mulliez, T Mulliez, T Mulliez, T Mulliez, T Viren, TE Merchant, TJ Whelan, Tom Van Hoof, Wilfried De Neve, X Gao   +56 more
core   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

Radiation Oncology, 2018
In the original publication [1] one author name was spelled incorrect.
Sophie Espenel, Max-Adrien Garcia, Jane-Chloé Trone, Elodie Guillaume, Annabelle Harris, Amel Rehailia-Blanchard, Ming Yuan He, Sarra Ouni, Alexis Vallard, Chloé Rancoule, Majed Ben Mrad, Céline Chauleur, Guy De Laroche, Jean-Baptiste Guy, Pablo Moreno-Acosta, Nicolas Magné   +15 more
doaj   +1 more source

Assessment of Occupational Exposure to External Radiation among Workers at the Institute of Radiotherapy and Nuclear Medicine, Pakistan (2009-2016) [PDF]

Iranian Journal of Medical Physics, 2017
Introduction: Assessment of occupational exposure to external radiation and the analysis of associated trends are imperative to observe changes that have taken place over time due to regulatory operations or technological advancements.
Misbah Ahmad, Habib Ahmad, Muhammad Khattak, Kamran Shah, Wajeeha Shaheen, Jawad Shah, Shaheen Iqbal   +6 more
doaj   +1 more source

Antiangiogenics and radiotherapy

Journal of Pharmacy and Pharmacology, 2008
Abstract Antiangiogenic therapies are one of the fore-runners of the new generation of anticancer drugs aimed at tumour-specific molecular targets. Up until the beginning of this century, the general opinion was that targeted agents should show antitumour activity when used as single agents.
Shannon, Aoife M., Williams, Kaye J.
openaire   +4 more sources